Pan-cancer analysis verifies COLGALT1 as a potential target for immunotherapy and survival prognosis

被引：0
|
作者：
Wang, Fengyan [1 ]
机构：
[1] Shandong First Med Univ & Shandong Prov Qianfosha, Affiliated Hosp 1, Jinan, Peoples R China
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2023年 / 38卷
关键词：
COLGALT1; immune cell infiltration; immunotherapy; pancancer; tumor immune microenvironment;
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
No.0161
引用
收藏
页码：49 / 49
页数：1
相关论文
共 50 条
  • [31] Pan-cancer analysis and single-cell analysis reveals FAM110B as a potential target for survival and immunotherapy
    Li, Yuwei
    Li, Xiaoxi
    Wu, Bihua
    Su, Shuangyan
    Su, Yunpeng
    Guo, Le
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2024, 11
  • [32] Pan-cancer analysis of BRK1 as a potential immunotherapeutic target
    Wang, Xuefeng
    Tang, Yanru
    Liu, Rui
    Li, Wentao
    Liu, Shiyue
    Zhou, Xinhong
    BIOTECHNOLOGY AND GENETIC ENGINEERING REVIEWS, 2024, 40 (03) : 1591 - 1613
  • [33] Pan-cancer analysis of NLRP3 inflammasome with potential implications in prognosis and immunotherapy in human cancer
    Ju, Mingyi
    Bi, Jia
    Wei, Qian
    Jiang, Longyang
    Guan, Qiutong
    Zhang, Ming
    Song, Xinyue
    Chen, Ting
    Fan, Jingyi
    Li, Xiaojuan
    Wei, Minjie
    Zhao, Lin
    BRIEFINGS IN BIOINFORMATICS, 2021, 22 (04)
  • [34] Pan-cancer analysis: predictive role of TAP1 in cancer prognosis and response to immunotherapy
    Tu, Zewei
    Li, Kuangxun
    Ji, Qiankun
    Huang, Yuyang
    Lv, Shigang
    Li, Jingying
    Wu, Lei
    Huang, Kai
    Zhu, Xingen
    BMC CANCER, 2023, 23 (01)
  • [35] Comprehensive analysis of the potential biological significance of CCL5 in pan-cancer prognosis and immunotherapy
    Shan, Jingjing
    Xu, Yan
    Lun, Yu
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [36] Pan-cancer analysis: predictive role of TAP1 in cancer prognosis and response to immunotherapy
    Zewei Tu
    Kuangxun Li
    Qiankun Ji
    Yuyang Huang
    Shigang Lv
    Jingying Li
    Lei Wu
    Kai Huang
    Xingen Zhu
    BMC Cancer, 23
  • [37] Pan-Cancer Analysis of PDIA3: Identifying It as a Potential Biomarker for Tumor Prognosis and Immunotherapy
    Zhang, Jing
    Wang, Kai
    Hainisayimu, Tuersun
    Li, Hui
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2022, 2022
  • [38] Pan-cancer analysis of DCBLD1 and its association with the diagnosis, immunotherapy, and prognosis of cervical cancer
    Shen, Qilong
    Qiu, Liping
    Zhou, Yinjian
    Wang, Longling
    Pan, Jiewei
    Zhang, Xiaoxing
    Chen, Yun
    Yao, Huaqi
    Wang, Junlin
    Yu, Xieyan
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2025, 148
  • [39] Pan-Cancer Analysis of the Oncogenic and Immunological Role of RCN3: A Potential Biomarker for Prognosis and Immunotherapy
    Ding, Jian
    Meng, Yan
    Han, Zelong
    Luo, Xiaobei
    Guo, Xuxue
    Li, Yiwen
    Liu, Side
    Zhuang, Kangmin
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [40] Pan-Cancer Analysis and Experimental Validation of SOX4 as a Potential Diagnosis, Prognosis, and Immunotherapy Biomarker
    Deng, Xinna
    Wang, Yashu
    Guo, Hao
    Wang, Qian
    Rao, Shuting
    Wu, Haijiang
    CANCERS, 2023, 15 (21)
12345